Cases & Deals

CARMAT completes €52.9 million capital increase

Clients CARMAT SA

Jones Day represented CARMAT SA, a designer and developer of the world's most advanced heart project, aiming to provide a therapeutic alternative for people suffering from end-stage biventricular heart failure, in connection with its €52.9 million (US$62.3 million) capital increase implemented without shareholders’ preferential subscription rights by way of a public offering and with a priority subscription period, on an irreducible basis only, to existing shareholders.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.